Department of Clinical Nutrition, West China Second Hospital, 198150Sichuan University, Chengdu 610041, China P.R.
Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Chengdu 610041, China P.R.
Benef Microbes. 2024 Jul 17;15(5):495-513. doi: 10.1163/18762891-bja00019.
Childhood obesity is a crucial public health concern worldwide. Dietary intervention is the most common intervention for the treatment of obesity. Therefore, we tested an improved diet-based nutritional interventions to improve the childhood obesity and its gut microbiota. Thirty obese children received a 12-week intervention with the adjust-energy-restricted dietary pattern (A-CRD). Body composition was measured by bioelectrical impedance (Inbody S10) and faecal microbes were profiled by sequencing 16S rRNA. Compared to the NTB group (at 0 week), the NTA group (at 12 weeks) had a significantly greater decrease in body weight, body mass index (BMI) and percent body fat (PBF) ( P < 0.001, respectively), whereas skeletal muscle mass (SMM) and fat free mass (FFM) were not statistically significantly different ( P > 0.05). The gut microbiota was found significantly different between the NTB and NTA groups based on alpha and beta diversity. Bifidobacterium, Blautia, and Streptococcus was significantly increased, whereas Bacteroides and Megamonas was significantly decreased in the NTA group ( P < 0.05, respectively). Meanwhile, NTA group significantly increased the ability to produce short-chain fatty acids (SCFAs; e.g. acetic acid/total dietary energy) and changed he predictive metabolic functional features of the microbiota communities ( P < 0.05, respectively) than the NTB group. In conclusion, A-CRD can significantly improve childhood obesity, and the underlying mechanism may be its effect on gut microbiota and metabolism. Therefore, the diet-based nutrition intervention targeting gut microbiota will be more effective management of body weight and prevention of obesity. Chinese Clinical Trial Register: ChiCTR2300074571.
儿童肥胖是全球范围内一个重要的公共卫生问题。饮食干预是治疗肥胖最常见的干预措施。因此,我们测试了一种改良的基于饮食的营养干预措施,以改善儿童肥胖及其肠道微生物群。三十名肥胖儿童接受了为期 12 周的调整能量限制饮食模式(A-CRD)干预。通过生物电阻抗(Inbody S10)测量身体成分,通过 16S rRNA 测序分析粪便微生物。与 NTB 组(0 周)相比,NTA 组(12 周)的体重、体重指数(BMI)和体脂百分比(PBF)显著下降(P<0.001),而骨骼肌质量(SMM)和无脂肪质量(FFM)没有统计学差异(P>0.05)。基于 alpha 和 beta 多样性,发现 NTB 和 NTA 组之间的肠道微生物群存在显著差异。双歧杆菌、布劳特氏菌和链球菌显著增加,而拟杆菌和Megamonas 显著减少(P<0.05)。同时,NTA 组显著增加了产生短链脂肪酸(SCFA;例如,乙酸/总膳食能量)的能力,并改变了微生物群落的预测代谢功能特征(P<0.05),而 NTB 组则没有。总之,A-CRD 可显著改善儿童肥胖,其潜在机制可能是其对肠道微生物群和代谢的影响。因此,针对肠道微生物群的基于饮食的营养干预可能是更有效的体重管理和肥胖预防措施。中国临床试验注册中心:ChiCTR2300074571。